Monte Rosa Therapeutics Inc Net Asset Quality Index
Monte Rosa Therapeutics Inc net asset quality index. Monte Rosa Therapeutics Inc (GLUE) has a Net Asset Quality Index of 69.7% as of June 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of $696.08 Million minus total liabilities of $211.03 Million yields net assets of $485.05 Million. A higher index indicates a stronger, lower-leverage balance sheet. See net assets of Monte Rosa Therapeutics Inc for net asset value and shareholders' equity analysis.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of Monte Rosa Therapeutics Inc (2019–2025)
Net asset quality index of Monte Rosa Therapeutics Inc from 2019 to 2025. This chart shows how Monte Rosa Therapeutics Inc's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 69.7%, representing net assets of $485.05 Million against total assets of $696.08 Million USD. Check Monte Rosa Therapeutics Inc strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Monte Rosa Therapeutics Inc Net Asset Quality Index by Year (2019–2025)
Monte Rosa Therapeutics Inc net asset quality index by year from 2019 to 2025. The table below presents the year-by-year Net Asset Quality Index for Monte Rosa Therapeutics Inc from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Monte Rosa Therapeutics Inc market capitalisation.
| Year | Quality Index | Net Assets (USD) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 51.9% | $233.06 Million | $448.66 Million | $215.60 Million | ▲ +1.1 pp |
| 2024 | 50.8% | $222.94 Million | $438.73 Million | $215.80 Million | ▼ -8.2 pp |
| 2023 | 59.0% | $179.25 Million | $303.75 Million | $124.50 Million | ▼ -20.3 pp |
| 2022 | 79.3% | $271.41 Million | $342.39 Million | $70.98 Million | ▼ -15.6 pp |
| 2021 | 94.9% | $347.51 Million | $366.33 Million | $18.81 Million | ▲ +193.5 pp |
| 2020 | -98.7% | $-48.73 Million | $49.38 Million | $98.11 Million | ▲ +10.8 pp |
| 2019 | -109.5% | $-12.15 Million | $11.09 Million | $23.24 Million | — |